Antares Pharma, Inc. (ATRS)

Cash & Short-Term Investments

$62.21M

Quarterly · Period ending: · USD

ATRS logo

ATRS Cash & Short-Term Investments

Latest reported$67.16M
ATRS FY Cash & Short-Term Investments ($11.04M → $67.16M)
High-resolution chart · PNG

ATRS cash & short-term investments history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Antares Pharma, Inc. Cash & Short-Term Investments — Annual fiscal periods (USD)
Period endingCash & Short-Term Investments (USD)
67,158,000
53,137,000
45,721,000
27,892,000
31,555,000
27,714,588
47,910,901
40,031,327
63,081,541
73,209,687
31,369,320
9,847,813
13,559,088
13,096,298
26,059,768
7,659,468
2,718,472
9,624,033
1,928,815
267,945
1,965,089
223,591
85,136
2,852,285
7,283,334
11,039,517
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.